Royal Bank of Canada’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Royal Bank of Canada’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,770	Closed	-$5K	–	7859
2023 Q4	$5K	Buy	3,770 +1,098	+41%	+$1.19K	﹤0.01%	6668
2023 Q3	$2K	Buy	2,672 +1,079	+68%	+$1.18K	﹤0.01%	6839
2023 Q2	$2K	Buy	1,593 +1,592	+159,200%	+$7.96K	﹤0.01%	6933
2023 Q1	$0	Sell	1 -1	-50%	-$9	﹤0.01%	7665
2022 Q4	$0	Sell	2 -22	-92%	-$138	﹤0.01%	7942
2022 Q3	$0	Buy	+24	New	+$151	﹤0.01%	8047
2022 Q2	–	Sell	-978	Closed	-$5K	–	7886
2022 Q1	$5K	Sell	978 -2,609	-73%	-$20.9K	﹤0.01%	7280
2021 Q4	$46K	Buy	3,587 +2,768	+338%	+$39.5K	﹤0.01%	6420
2021 Q3	$12K	Buy	819 +216	+36%	+$3.68K	﹤0.01%	6914
2021 Q2	$9K	Buy	+603	New	+$10.6K	﹤0.01%	6925

Royal Bank of Canada's RAIN Position: Q1 2024 in Review

Royal Bank of Canada sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 3,770 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in RAIN in Q2 2021 and held it in 10 quarters. The position peaked at $46K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Royal Bank of Canada reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Royal Bank of Canada sold 3,770 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $5K.
Royal Bank of Canada first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Royal Bank of Canada's Rain Oncology Inc. Common Stock position peaked at $46K in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.